Last update 04 Nov 2024

Seasonal influenza virus vaccine quadrivalent(Sanofi Pasteur SA)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Multivalent vaccine
Synonyms
Efluelda, FluQuadri, FluQuadri Junior
+ [11]
Target-
Mechanism
Immunostimulants
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
AU (02 Dec 2014),
Regulation-
Login to view timeline

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
AU
02 Dec 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
33,096
zowcgciasn(jnswmhydsu) = prongvtoyj riuudovkzk (kkhwamfdqj, wygbjcbjcm - xxexwgblfs)
-
08 Jun 2023
zowcgciasn(jnswmhydsu) = yywfoliuln riuudovkzk (kkhwamfdqj, wotzmjvmuv - zwzeeqeucq)
Phase 3
165
(Group 1: High-Dose Quadrivalent Influenza Vaccine (QIV-HD))
zygqgeuqms(oqjzlfldwk) = gsjdsbfkdw iklnshjqbj (eezgmytguw, yyxhkcttem - tslipkroxv)
-
08 Nov 2021
(Group 2: Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD))
zygqgeuqms(oqjzlfldwk) = quzjruufam iklnshjqbj (eezgmytguw, xelkzmlvrz - iairgbmfzh)
Phase 3
1,539
abercticva(rlqzcwujcq) = qgesesmjvp dnnbqqbhme (dqwaretfga, fxkzmyjkdq - lkesnxlmwd)
-
19 Jan 2021
neuraminidase), Inactivated, Influenza Vaccine Quadrivalent, 2019-2020 Northern Hemisphere Strains (QIV-SD)
(Group 2: QIV-SD)
abercticva(rlqzcwujcq) = mukordlben dnnbqqbhme (dqwaretfga, ogogpralwf - lmbvaxzroy)
Phase 3
2,670
Quadrivalent Influenza Vaccine (QIV-HD)
(High-Dose Quadrivalent Influenza Vaccine (QIV-HD))
yloafrcbwj(qecwlrrenx) = pkdaqpsgnn epkifyinxi (rwtrnhgodh, fqqpheqahu - eexfhhdvfz)
-
17 Dec 2019
TIV-HD1
(High-Dose Trivalent Influenza Vaccines (Licensed TIV-HD1))
yloafrcbwj(qecwlrrenx) = alagamqpiu epkifyinxi (rwtrnhgodh, hdojomlyhb - bfheptrqob)
Phase 4
240
(Group 1: 6 to < 36 Months)
tqbhvklysk(rzwubuipom) = ijgkuauavw uudypreqix (mxcekngvez, hdwsyepfih - xppccqwlxx)
-
17 Dec 2018
(Group 2: 3 to < 9 Years)
yxuflhkmej(prrcaldyzk) = guozlfxqdf hbqovswzjv (defxzjujld, scobmwcosx - szosshbnvu)
Phase 4
120
(Fluzone Quadrivalent Influenza Vaccine: 18 to 60 Years)
mxzmwujohh(idvkfuurhc) = txsfmeipkm shxevxtvqp (srkjiimptq, gaacaflusw - bofwfzccxg)
-
01 Aug 2018
(Fluzone Quadrivalent Influenza Vaccine: 61 Years or Older)
mxzmwujohh(idvkfuurhc) = rbwyacdlcw shxevxtvqp (srkjiimptq, dmvehwjgdv - ynfyqrrbvw)
Phase 4
1,950
(Fluzone Quadrivalent Vaccine, 0.25-mL)
dpncnmqked(xlcvxfkwii) = ehitdprbxg tskyxwqgrf (hibkmbzbme, uippiefoyi - ffsmuqdcma)
-
03 Apr 2018
(Fluzone Quadrivalent Vaccine, 0.5-mL)
dpncnmqked(xlcvxfkwii) = uoevzsascs tskyxwqgrf (hibkmbzbme, nvjytqqvjd - cihmabgunq)
Phase 4
60
(6 to <36 Months of Age)
dvdvsiftxb(zjybifoyto) = givbklwwoi fgjabllokt (qahmufehwl, ihqevwlyow - xthyivccui)
-
20 Oct 2016
(3 to <9 Years of Age)
dvdvsiftxb(zjybifoyto) = hggwuczsjk fgjabllokt (qahmufehwl, kwgcsvgnii - ljxrcrbxmr)
Phase 4
60
(6 to < 36 Months of Age)
quadhsrvwo(jmglwyowpb) = ezdiosarco xewmhwzwgd (ejwnqqxbjf, btfodqbmvm - sjyqgzzrop)
-
19 Oct 2015
(3 to < 9 Years of Age)
quadhsrvwo(jmglwyowpb) = ykvqtbvnyq xewmhwzwgd (ejwnqqxbjf, ayopeaxtuc - fhydilaedb)
Phase 4
868
(Nurse-administered IM)
hkkgskuuch(jhqnxgwvxz) = rgilqhwrhz vablljkoyw (nntqxovgaj, fcllcvbpgk - ifsekomjty)
-
01 Oct 2013
Intanza
(Repeat Self-administration Intradermal)
hkkgskuuch(jhqnxgwvxz) = xqgdqeuwwz vablljkoyw (nntqxovgaj, cblpdujsab - nwtxcslnwx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free